The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-((1-(5-aminopentylamino)isoquinolin-4-yl)methyl)-7-(3-hydroxypropylthio)-4-isobutyl-2-methyl-2,6-dihydro-1H-pyrrolo[3,4-d]pyridazin-1-one ID: ALA3818311
PubChem CID: 127052807
Max Phase: Preclinical
Molecular Formula: C29H40N6O2S
Molecular Weight: 536.75
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)Cc1nn(C)c(=O)c2c(SCCCO)n(Cc3cnc(NCCCCCN)c4ccccc34)cc12
Standard InChI: InChI=1S/C29H40N6O2S/c1-20(2)16-25-24-19-35(29(38-15-9-14-36)26(24)28(37)34(3)33-25)18-21-17-32-27(31-13-8-4-7-12-30)23-11-6-5-10-22(21)23/h5-6,10-11,17,19-20,36H,4,7-9,12-16,18,30H2,1-3H3,(H,31,32)
Standard InChI Key: UKBMJQCYJYSUFI-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 41 0 0 0 0 0 0 0 0999 V2000
-6.4133 -6.8760 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.1764 -5.5904 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.4385 -4.2619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8936 -6.8644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1714 -5.5451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9345 -4.2596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9443 -3.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5870 -3.7544 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.7158 -5.2111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2779 -7.8944 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-7.1996 -2.9687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.7004 -2.9802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.3090 -1.9460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.2921 -4.0242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.0029 -7.9211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5797 -6.1883 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.1630 -5.6929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9749 -6.6715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3917 -6.1761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3015 -6.9585 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2907 -2.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2907 2.9981 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5870 3.7544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5812 5.2552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8775 6.0115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8717 7.5123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1681 8.2686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1634 9.4686 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 1 0
2 3 2 0
3 6 1 0
5 4 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 5 2 0
4 10 2 0
3 11 1 0
11 12 1 0
12 13 1 0
12 14 1 0
1 15 1 0
9 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
8 21 1 0
21 22 1 0
22 27 1 0
26 23 1 0
23 24 2 0
24 25 1 0
25 22 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 26 2 0
23 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
37 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 536.75Molecular Weight (Monoisotopic): 536.2933AlogP: 4.55#Rotatable Bonds: 14Polar Surface Area: 110.99Molecular Species: BASEHBA: 9HBD: 3#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 10.21CX LogP: 3.57CX LogD: 0.84Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.16Np Likeness Score: -0.63
References 1. Nair RN, Mishra JK, Li F, Tortosa M, Yang C, Doherty JR, Cameron M, Cleveland JL, Roush WR, Bannister TD.. (2016) Exploiting the co-reliance of tumours upon transport of amino acids and lactate: Gln and Tyr conjugates of MCT1 inhibitors., 7 (5): [PMID:27347360 ] [10.1039/c5md00579e ] 2. Wang Y, Qin L, Chen W, Chen Q, Sun J, Wang G.. (2021) Novel strategies to improve tumour therapy by targeting the proteins MCT1, MCT4 and LAT1., 226 [PMID:34517305 ] [10.1016/j.ejmech.2021.113806 ] 3. Murray, Clare M CM and 26 more authors. 2005-12 Monocarboxylate transporter MCT1 is a target for immunosuppression. [PMID:16370372 ] 4. Wang, Hui H and 5 more authors. 2014-09-11 Synthesis and structure-activity relationships of pteridine dione and trione monocarboxylate transporter 1 inhibitors. [PMID:25068893 ] 5. Nair, Reji N and 9 more authors. 2016-05-01 Exploiting the co-reliance of tumours upon transport of amino acids and lactate: Gln and Tyr conjugates of MCT1 inhibitors. [PMID:27347360 ]